Two nondoped blue fluorescent OLEDs based on benzonitrile-anthracene derivatives with 10.06% and 9.23% EQE and low efficiency roll-off were fabricated.
A series of blue thermally activated delayed fluorescence (TADF) emitters were designed and synthesized, using 2,4,6-triphenyl-1,3,5-triazine as the acceptor unit, and indenocarbazole derivatives as the electron-donating moiety. In contrast with other six-membered heterocycles, like phenothiazine, phenoxazine and dihydroacridine, where the TADF efficiency is affected by the presence of different conformers, indenocarbazole derivatives do not show this effect. Therefore, InCz23FlTz, InCz23DPhTz, InCz23DMeTz and InCz34DPhTz allow to investigate the influence of different substituents and substitution positions on TADF properties, without the difficulty of having to deal with changes on conformation.We demonstrate that the substituted position on the carbazole and different substituents in the same position have clear influence on the donor character of indenocarbazole derivatives. Also, the color purity of blue emission and excited states could be adjusted by substituents and substituted position, thus excellent blue emitters can be obtained. Besides, the four compounds show relatively small TADF contribution under optical excitation, however excellent performances are obtained in the electroluminescent devices, especially with InCz34DPhTz, which shows a maximum external quantum efficiency (EQE) around 26%. In the end, we find an effective way to design high efficiency blue TADF materials and deeply study the relation between structure and property in indenocarbazole derivatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.